There is one clinical trial.

Clinical Trials

1 Multicenter Randomized Controlled Trial of the Efficacy of Melatonin in the Prophylaxis of SARS-coronavirus-2 Infection Among High Risk Contacts.

There is an urgent need to evaluate interventions that can prevent the infection with SARS-CoV 2 of healthcare workers at risk. Melatonin is an inexpensive and safe product with protective effect in both bacterial and viral infections likely due to its anti-inflammatory and anti-oxidative effects. This randomized controlled trial seeks to evaluate is efficacy as a prophylaxis in healthcare workers exposed to the virus in their clinical practice.

NCT04353128 Covid19 SARS-CoV 2 Coronavirus Infection Drug: Melatonin 2mg Drug: Placebo oral tablet

MeSH:Infection Coronavirus Infections Severe Acute Respiratory Syndrome

No related HPO nodes (Using clinical trials)